首页> 外文期刊>Journal of clinical anesthesia >Implementation of an intraoperative glycemic control protocol for cardiac surgery in a high-acuity academic medical center: An observational study
【24h】

Implementation of an intraoperative glycemic control protocol for cardiac surgery in a high-acuity academic medical center: An observational study

机译:在高学历学术医学中心实施心脏手术的术中血糖控制方案:一项观察性研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Study Objective To examine the effect on morbidity and mortality of an established intraoperative insulin protocol in cardiac surgical patients. Design Retrospective observational study. Setting Single-center, 782 bed, metropolitan academic hospital. Patients 1,616 adult patients undergoing cardiac surgical procedures with cardiopulmonary bypass (CPB). Interventions An intraoperative, intravenous (IV) insulin protocol designed to maintain blood glucose values less than 150 mg/dL was implemented. Measurements Blood glucose was evaluated on entry to the operating room, every 30 minutes during CPB, and at least once after discontinuation of CPB. Blood glucose values were followed postoperatively, as dictated by institutional policy. Main Results Intraoperative predictors of 30-day mortality using multivariate logistic regression included hyperglycemia on initiation of CPB (OR 1.0, P = 0.05). The strongest predictor of 30-day mortality was the development of postoperative renal failure requiring hemodialysis (OR 3.26, P = 0.001). Conclusions Implementation of an intraoperative IV insulin protocol, while associated with improved glycemic control, was not associated with improved outcomes. While improved glycemic control on initiating CPB was associated with decreased 30-day mortality, the effect was small. Implementation of our insulin protocol was highly associated with decreased renal failure postoperatively. Further prospective studies are warranted to better establish causality.
机译:研究目的探讨已建立的术中胰岛素治疗方案对心脏外科手术患者的发病率和死亡率的影响。设计回顾性观察研究。设置782张病床的单中心大都市学术医院。患者1,616名成年患者正在接受体外循环(CPB)心脏外科手术。干预实施了旨在维持血糖值低于150 mg / dL的术中静脉(IV)胰岛素方案。测量在进入手术室时,CPB期间每30分钟以及在CPB停止后至少一次评估血糖。根据机构政策,术后随访血糖值。主要结果采用多因素logistic回归分析术中30天死亡率的术中预测因素包括CPB开始时的高血糖(OR 1.0,P = 0.05)。 30天死亡率的最强预测指标是需要进行血液透析的术后肾衰竭的发生(OR 3.26,P = 0.001)。结论术中静脉胰岛素方案的实施与改善血糖控制有关,但与改善预后无关。虽然开始CPB时血糖控制的改善与30天死亡率的降低有关,但效果很小。胰岛素方案的实施与术后肾功能衰竭的减少高度相关。必须进行进一步的前瞻性研究以更好地确定因果关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号